Asciminib Treatment Optimization in ≥ 3rd Line CML-CP
Novartis
Novartis
Takeda
Gamida Cell ltd
Novartis
Novartis
Novartis
Novartis
Shenzhen TargetRx, Inc.
Novartis
Novartis
American Regent, Inc.
Novartis
Novartis
Ascentage Pharma Group Inc.
Novartis
Advice Pharma Group srl
Astellas Pharma Inc
Astex Pharmaceuticals, Inc.
Pfizer
Novartis
Novartis
Novartis
Novartis
Sumitomo Pharma America, Inc.
Pfizer
Incyte Corporation
Hikma Pharmaceuticals LLC
Novartis
Novartis
Fate Therapeutics
Karyopharm Therapeutics Inc
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Novartis
Novartis
Novartis
Pfizer
Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers Squibb
Takeda
Pfizer
Incyte Corporation
Notable Labs
Xencor, Inc.
Teva Branded Pharmaceutical Products R&D, Inc.
Incyte Corporation
Novartis
Novartis
Nohla Therapeutics, Inc.
Novartis